For Investors

Sales of Olainfarm in Ten Months Exceed 81 Million Euro

on 16 lapkričio, 2015 Komentavimas išjungtas įraše Sales of Olainfarm in Ten Months Exceed 81 Million Euro

Preliminary consolidated sales results of JSC Olainfarm for October 2015 show that sales during this months have reached 8.38 million euros, which represents an increase by 1% compared to the same period of 2014. The biggest sales increase was achieved in Ukraine, where sales grew by 9094%. Sales to Switzerland grew by 572%, while sales to Kazakhstan grew by 100%. During October 2015 significant shipments were also made to Brazil. Major sales markets of  JSC Olainfarm during October 2015 were Russia, Latvia, Ukraine, Belarus and Kazakhstan.

October 2015, consolidated sales Share in total sales Changes to October 2014
Russia 26% -41%
Latvia 26% 8%
Ukraine 22% 9094%
Belarus 9% 18%
Kazakhstan 4% 100%
Brazil 2% NA
Poland 1% -22%
Switzerland 1% 572%
Albania 1% 26%
Turkmenistan 1% -21%
Other 7% -59%
Total 100% 1%

 

Sales of pharmacy chain of Latvijas Aptieka Ltd., fully owned by JSC Olainfarm, were 1.6 million euros in October 2015.  This represents an increase by 8%, compared to October 2014.  59 pharmacies were operating during this period.  Sales of Silvanols Ltd. during October 2015 were 0.39 million euros, which represents a reduction by 3% compared to the same period one year ago.  Silvanols Ltd. sold its products to four European countries directly and to Belarus and Azerbaijan via system of JSC Olainfarm.

According to preliminary consolidated results for ten months of 2015, sales of JSC Olainfarm have reached 81.42 million euros, which represents an increase by 4% compared to the same period of 2014.  The most rapid sales increase was achieved in The Netherlands, where sales grew by 181%.  Major sales markets of JSC Olainfarm during this period were Russia Ukraine, Latvia, Belarus and The Netherlands.

10 months of 2015, consolidated sales Share in total sales Changes to 10 months of 2014
Russia 33% -8%
Ukraine 13% 3%
Latvia 23% 9%
Belarus 7% -5%
The Netherlands 6% 181%
Kazakhstan 3% 12%
UK 2% -7%
Uzbekistan 1% -4%
Tajikistan 1% 28%
Poland 1% -25%
Other 9% 8%
Total 100% 4%

 

Sales of chain of pharmacies of  Latvijas Aptieka Ltd. during ten months of 2015 were 13.8 million euros, which represents an increase by 10% compared to ten months of 2014.  Sales of Silvanols Ltd. in ten months were 3.3 million euros, this represents an increase by 19% compared to same period of 2014, when it made sales of 2.78 million euros.  During this period Silvanols Ltd. sold its products to 13 countries in two continents, and via system of JSC Olainfarm to Belarus, Azerbaijan and Kazakhstan.

According to preliminary unconsolidated results, sales of JSC Olainfarm during October 2015 were 7.24 million euros, which represents an increase by 7% compared to the same period of 2014. The biggest sales increase was achieved in Poland, where sales grew by 173 513%. Sales to Ukraine grew by 9094%, sales to Switzerland grew by 572%, but sales to Kazakhstan grew by 100%. During this period significant shipments were also made to Brazil.  Major sales markets of JSC Olainfarm during October 2015 were Russia, Ukraine, Latvia, Belarus and Kazakhstan.  During October 2015, JSC Olainfarm sold its products to 24 countries on three continents.

October 2015, unconsolidated sales Share in total sales Changes to October 2014
Russia 30% -41%
Ukraine 25% 9094%
Latvia 15% 5%
Belarus 10% 18%
Kazakhstan 5% 100%
Brazil 2% NA
Poland 2% 173513%
Switzerland 1% 572%
Albania 1% 26%
Turkmenistan 1% -21%
Other 7% -48%
Total 100% 7%

 

According to preliminary unconsolidated results for ten months of 2015, sales of JSC Olainfarm were 71.49 million euros, which represents an increase by 5% compared to the same period one year ago.   The most rapid sales increase during this period was achieved in The Netherlands, where sales grew by 181%.  Sales to Turkmenistan grew by 35%, sales to Tajikistan and Latvia grew by 28%.  According to preliminary unconsolidated results, major sales markets of JSC Olainfarm in ten months of 2015 were Russia, Ukraine, Latvia, Belarus and The Netherlands. In total during this ten months period products of JSC Olainfarm were sold to 42 countries on five continents.

10 months of 2015, unconsolidated sales Share in total sales Changes to 10 months of 2014
Russia 38% -8%
Ukraine 15% 3%
Latvia 14% 28%
Belarus 8% -5%
The Netherlands 7% 181%
Kazakhstan 3% 12%
UK 2% -7%
Uzbekistan 2% -4%
Tajikistan 1% 28%
Turkmenistan 1% 35%
Other 9% 1%
Total 100% 5%

 

Annual General Meeting of shareholders of JSC Olainfarm, held on June 11, 2015 approved operating plan of the company, according to which the unconsolidated sales of the company in 2015 will reach 87 million euros, while consolidated sales will reach 100 million euro.  According to these preliminary sales figures, in ten months of 2015, the company has attained 82% of annual target for unconsolidated sales and 81% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

read more
Sales of Olainfarm in Ten Months Exceed 81 Million Euro

Olainfarm to Go on Baltic – Nordic Roadshow

on 23 spalio, 2015 Komentavimas išjungtas įraše Olainfarm to Go on Baltic – Nordic Roadshow

From October 26-30 Member of the Board of JSC Olainfarm and company’s Investor Relations Officer Salvis Lapins will go on Roadshow to inform investors and shareholders of Baltic and Nordic region about company’s performance, important issues and future intentions.

„Late October Baltic – Nordic roadshows are turning into annual tradition. During meetings, we reflect of results and discuss our plans for the future. We highly value these meetings, and I believe, both, us and investors are looking forward to them as direct contact allows us to better convey our message and better feel the sentiment among investors,” says Salvis Lapins, Member of the Board and Investor Relations Officer.

On October 26 meetings will take place in Tallinn, on October 27th in Helsinki, on October 28th in Stockholm, and on October 29 and 30 in Vilnius. In total about 20 meetings will be held, during which the enclosed presentation will be discussed:

Baltic – Nordic Roadshow Presentation

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:

Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Olainfarm to Go on Baltic – Nordic Roadshow

Sales of Olainfarm in Nine Months Reaches 73 Million Euro

on 15 spalio, 2015 Komentavimas išjungtas įraše Sales of Olainfarm in Nine Months Reaches 73 Million Euro

Preliminary consolidated results of JSC Olainfarm for September, 2015 show that sales of the company during this period has reached 8.03 million euro, which represents a reduction by 5% compared to the same period of 2014.  The biggest sales increases were achieved in Ukraine, where sales grew by 77% and Uzbekistan, where sales grew by 60%. Significant shipments have also been made to Germany and Australia.  The major sales markets of JSC Olainfarm during September were Russia, Latvia, Ukraine, Belarus, The Netherlands and Poland.

September 2015, consolidated sales Share in total sales Changes to September 2014
Russia 28% -27%
Latvia 26% 5%
Ukraine 15% 77%
Belarus 6% -9%
The Netherlands 5% 21%
Poland 5% 8%
Uzbekistan 3% 60%
Germany 2% NA
Lithuania 2% 13%
Australia 2% NA
Other 8% -51%
Total 100% -5%

 

Sales of pharmacy chain of Latvijas aptieka Ltd., fully owned by JSC Olainfarm were 1.43 million euros, which represents an increase by 8% compared to the same period of 2014; 57 pharmacies were operating during September. Sales of Silvanols Ltd. during September were 0.54 million euro, and this represents an increase by 15% compared to 2014.  Silvanols was selling its products in six European countries directly. Sales to Kazakhstan were made via JSC Olainfarm.

According to preliminary consolidated results for nine months of 2015, sales of JSC Olainfarm during this period were 73.03 million euro, which represents an increase by 4% compared to nine months of 2014.  The most rapid sales increases in nine months were achieved in The Netherlands, where sales grew by 181%. Major sales markets of JSC Olainfarm in nine months of 2015 were Russia, Latvia, Ukraine, Belarus and The Netherlands.

9 months of 2015, consolidated sales Share in total sales Changes to nine months of 2014
Russia 34% -3%
Latvia 23% 9%
Ukraine 12% -15%
Belarus 7% -7%
The Netherlands 7% 181%
Kazakhstan 2% 2%
UK 2% -9%
Uzbekistan 1% -6%
Poland 1% -32%
Lithuania 1% 18%
Other 9% 28%
Total 100% 4%

 

Sales of pharmacies of Latvijas aptieka Ltd. in nine months of 2105 were 12.2 million euro, which represents an increase by 10% compared to the same period of 2014.  Sales of Silvanols Ltd. in nine months of 2015 were 2.9 million euro, which is an increase by 22% compared to 2014. Silvanols Ltd. during this period made sales in 13 countries on two continents. Sales to Kazakhstan and Azerbaijan were made via JSC Olainfarm.

According to preliminary unconsolidated results, sales of JSC Olainfarm during September 2015 were 6.87 million euro, which represents a reduction by 6% compared to the same period of 2014. The biggest sales increases were achieved in Ukraine, where sales grew by 77%, Uzbekistan, where sales grew by 60%, and Lithuania, where sales grew by 24%. During this month, significant shipments have also been made to Germany and Australia. Major sales markets of JSC Olainfarm in September 2015 were Russia, Ukraine, Latvia, Belarus and The Netherlands. During September 2015, products of JSC Olainfarm were sold in 24 countries on five continents.

September 2015, unconsolidated sales Share in total sales Changes to September 2014
Russia 33% -27%
Ukraine 17% 77%
Latvia 17% 21%
Belarus 7% -9%
The Netherlands 6% 21%
Poland 4% -20%
Uzbekistan 3% 60%
Germany 2% NA
Lithuania 2% 24%
Australia 2% NA
Other 8% -53%
Total 100% -6%

 

According to preliminary unconsolidated results for nine months of 2015, sales of JSC Olainfarm during this period were 64.24 million euro, which represents an increase by 5% compared to the same period of 2014.  The most rapid sales increases were achieved in The Netherlands, where sales grew by 181%, sales to Turkmenistan grew by 48%, sales to Tajikistan grew by 36%, and sales to Latvia grew by 31%. Major sales markets of AS Olainfarm in none months of 2015 were Russia, Latvia, Ukraine, Belarus and The Netherlands. In total in nine months JSC Olainfarm made sales in 41 countries on five continents.

9 months of 2015, unconsolidated sales Share in total sales Changes to 9 months of 2014
Russia 38% -3%
Latvia 14% 31%
Ukraine 14% -15%
Belarus 8% -7%
The Netherlands 8% 181%
Kazakhstan 3% 2%
UK 2% -9%
Uzbekistan 2% -6%
Tajikistan 1% 36%
Turkmenistan 1% 48%
Other 9% 4%
Total 100% 5%

 

Annual General Meeting of shareholders of JSC Olainfarm, held on June 11, 2015 approved operating plan of the company, according to which the unconsolidated sales of the company in 2015 will reach 87 million euros, while consolidated sales will reach 100 million euro.  According to these preliminary sales figures, in nine months of 2015, the company has attained 74% of annual target for unconsolidated sales and 73% of annual target for consolidated sales.

 

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

read more
Sales of Olainfarm in Nine Months Reaches 73 Million Euro

Eight Months Sales of Olainfarm Increase by 5%

on 15 rugsėjo, 2015 Komentavimas išjungtas įraše Eight Months Sales of Olainfarm Increase by 5%

Preliminary consolidated sales figures of JSC Olainfarm for August 2015 show that sales of the company have reached 6.67 million euros, which is nearly the same amount as in August 2014. The biggest sales increases were achieved in India, where sales grew by 766%. Sales to Turkmenistan grew by 204%, sales to The Netherlands by 135%, while sales to Lithuania by 114%. Significant shipments during this period were also made to Uzbekistan. Major sales markets of JSC Olainfarm during August of 2015 were Russia, Latvia, Belarus, Ukraine and The Netherlands.

August 2015, consolidated sales Share in total sales Changes to August 2014
Russia 39% 13%
Latvia 24% 12%
Belarus 13% 18%
Ukraine 5% -72%
The Netherlands 5% 135%
Turkmenistan 3% 204%
Kazakhstan 2% -40%
Uzbekistan 2% NA
India 2% 766%
Lithuania 1% 114%
Other 3% -49%
Total 100% 0%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. during August 2105 were 1.25 million euros, which represents an increase by 10% compared to the same period one year ago. 58 pharmacies were operating during this period. Sales of Silvanols Ltd. during this period were 0.23 million euros, which represents an increase by 64% compared to August 2014. Silvanols Ltd. made its sales in seven European countries.

According to preliminary consolidated figures, sales of JSC Olainfarm in eight months of this year were 64.97 million euros, which represents a 5% increase compared to eight months of 2014. The most rapid sales increase during this period was achieved in The Netherlands, where sales increased by 218%, and in Tajikistan, where sales grew by 70%. Major sales market of JSC Olainfarm in eight months of 2015 were Russia, Latvia, Ukraine, Belarus and The Netherlands.

Eight months of 2015, consolidated sales Share in total sales Changes to eight months of 2014
Russia 34% 0%
Latvia 22% 9%
Ukraine 12% -21%
Belarus 7% -7%
The Netherlands 7% 218%
Kazakhstan 3% 17%
UK 2% -9%
Tajikistan 1% 70%
Uzbekistan 1% -15%
Lithuania 1% 19%
Other 9% 17%
Total 100% 5%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in eight months were 10.8 milion euros, which represents an increase by 11%compared to the same period one year ago. Sales of Silvanols Ltd. in eight months totaled 2.4 million euros, which represents an increase by 26% compared to eight months of 2014, when Silvanols Ltd. made sales worth 1.9 million euros. Silvanols Ltd. made its sales in 12 countries on two continents.

According to preliminary unconsolidated results, sales of JSC Olainfarm in August 2015 were 5.84 million euros, which is an increase by 1% compared to the same period one year ago. The biggest sales increase was achieved in India, where sales increased by 766%. Sales to Lithuania increased by 233%, Sales to Turkmenistan grew by 204%, but sales to The Netherlands grew by 135%. During August 2015, significant shipments were also made to Uzbekistan. Major sales markets of JSC Olainfarm in August 2015 were Russia, Latvia, Belarus, Ukraine and The Netherlands. During August 2015, JSC Olainfarm made sales in 16 countries in Europe, Asia and North America.

August 2015, unconsolidated sales Share in total sales Changes to August 2014
Russia 45% 13%
Latvia 15% 32%
Belarus 15% 18%
Ukraine 6% -72%
The Netherlands 5% 135%
Turkmenistan 3% 204%
Kazakhstan 3% -40%
Uzbekistan 2% NA
India 2% 766%
Lithuania 2% 233%
Other 2% -63%
Total 100% 1%

 

According to preliminary unconsolidated results, sales of JSC Olainfarm in eight months of 2015 were 57.36 million euros, which represents an increase by 7% compared to similar period of 2014. The most rapid sales increase was achieved in The Netherlands, where sales grew by 218%. Sales to Tajikistan grew by 70%, but sales to Latvia grew by 32%. According to preliminary unconsolidated results, the major sales markets of JSC Olainfarm in eight months of 2015 were Russia, Latvia, Ukraine, Belarus and The Netherlands. In total during eight months JSC Olainfarm made its sales in 38 countries in Europe, Asia, The Americas and Australia.

Eight months of 2015, unconsolidated results Share in total sales Changes to 8 months of 2014
Russia 39% 0%
Latvia 14% 32%
Ukraine 13% -21%
Belarus 8% -7%
The Netherlands 8% 218%
Kazakhstan 3% 17%
UK 3% -9%
Tajikistan 2% 70%
Uzbekistan 1% -15%
Lithuania 1% 9%
Other 8% 12%
Total 100% 7%

 

Annual General Meeting of shareholders of JSC Olainfarm, held on June 11, 2015 approved operating plan of the company, according to which the unconsolidated sales of the Company in 2015 will reach 87 million euros, while consolidated sales will reach 100 million euro. According to these preliminary sales figures, in eight months of 2015, the Company has attained 66% of annual target for unconsolidated sales and 65% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

 

read more
Eight Months Sales of Olainfarm Increase by 5%

Sales of Olainfarm in July increase by 19%

on 17 rugpjūčio, 2015 Komentavimas išjungtas įraše Sales of Olainfarm in July increase by 19%

Preliminary consolidated sales figures of JSC Olainfarm for July 2015 show that sales have reached 7.44 million euros, which represents an increase by 19% compared to the same period one year ago. The biggest sales increase was achieved in Belarus, where sales grew by 850%, while sales to Poland grew by 407%, sales to Tajikistan grew by 364%, sales to Kazakhstan grew by 215% and sales to Ukraine grew by 96%. During July 2015, significant shipments were also made to The Netherlands and Uzbekistan. Major sales markets of JSC Olainfarm during July were Russia, Latvia and Ukraine.

July 2015, consolidated sales Share in total sales Changes to July 2014
Russia 33% -29%
Latvia 22% 4%
Ukraine 16% 96%
Belarus 6% 850%
Kazakhstan 4% 215%
The Netherlands 3% NA
Tajikistan 3% 364%
Uzbekistan 3% NA
Poland 2% 407%
Turkmenistan 1% -13%
Other 8% 78%
Total 100% 19%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in July 2015 were 1.3 million euro, which represents an increase by 11% compared to July 2014. During July 2015 58 pharmacies were operating. Sales of Silvanols Ltd. during July 2015 were 0.16 million euros, which represents an increase by 33% compared to the same period of 2014. During July, Silvanols Ltd. sold its products in four European countries.

According to preliminary figures, in seven months of 2015 sales of JSC Olainfarm reached 58.32 million euros, which represents an increase by 6% compared to the same period of 2014. The most rapid sales increases during this period were achieved in The Netherlands , where sales increased by 227%, while sales to Tajikistan increased by 75% and sales to Kazakhstan increased by 31%. The major sales markets of JSC Olainfarm in seven months of 2015 were Russia, Latvian, Ukraine, The Netherlands and Belarus.

7 months of 2015, consolidated sales Share in total sales Changes to 7 months of 2014
Russia 34% -1%
Latvia 22% 9%
Ukraine 12% -13%
The Netherlands 7% 227%
Belarus 7% -12%
UK 3% -10%
Kazakhstan 3% 31%
Tajikistan 2% 75%
Uzbekistan 1% -28%
Lithuania 1% 11%
Other 9% 18%
Total 100% 6%

 

In seven months of 2015 the sales of pharmacy chain of Latvijas aptieka Ltd. was 9.5 million euro, which represents an increase by 11% compared to the same period one year ago. Sales of Silvanols Ltd. in seven months of 2015 were 2.2 million euros, which represents an increase by 33% compared to seven months of 2014, where its sales were 1.65 million euro. During seven months, products of Silvanols Ltd. were sold to 11 countries on two continents.

According to preliminary unconsolidated results, sales of JSC Olainfarm during July 2015 were 6.66 million euros, which represents an increase by 22% compared to the same period of 2014. The major sales increase was achieved in Belarus, where sales grew by 850%, while sales to Tajikistan grew by 364%, sales to Kazakhstan by 215% and sales to Ukraine by 96%. Significant shipments during this period have also been made to The Netherlands, Uzbekistan and Poland. Major sales markets of JSC Olainfarm during July 2015 were Russia, Ukraine and Latvia. During July 2015, products of JSC Olainfarm were sold in 24 countries on three continents.

July 2015, unconsolidated sales Share in total sales Changes to July 2014
Russia 37% -29%
Ukraine 18% 96%
Latvia 14% 12%
Belarus 6% 850%
Kazakhstan 4% 215%
The Netherlands 4% NA
Tajikistan 3% 364%
Uzbekistan 3% NA
Poland 2% NA
Turkmenistan 1% -13%
Other 8% 71%
Total 100% 22%

 

According to preliminary unconsolidated results in seven months of 2015 JSC Olainfarm has made sales worth 51.52 million euros, which represents an increase by 7% compared to the same period of 2014. The most rapid sales increase was achieved in The Netherlands, where sales grew by 227%, while sales to Tajikistan grew by 75%, sales to Latvia by 32% and sales to Kazakhstan by 31%. The major sales markets of JSC Olainfarm seven months of 2015 were Russia, Ukraine, Latvia, The Netherlands and Belarus. In total during seven months of 2015 products of JSC Olainfarm were sold to 38 countries on five continents.

7 months of 2015, unconsolidated sales Share in total sales Changes to 7 months of 2014
Russia 38% -1%
Ukraine 14% -13%
Latvia 14% 32%
The Netherlands 8% 227%
Belarus 7% -12%
UK 3% -10%
Kazakhstan 3% 31%
Tajikistan 2% 75%
Uzbekistan 1% -28%
Turkmenistan 1% 25%
Other 8% 8%
Total 100% 7%

 

Annual General Meeting of shareholders of JSC Olainfarm, held on June 11, 2015 approved operating plan of the company, according to which the unconsolidated sales of the Company in 2015 will reach 87 million euros, while consolidated sales will reach 100 million euro. According to these preliminary sales figures, in seven months of 2015, the Company has attained 59% of annual target for unconsolidated sales and 58% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

read more
Sales of Olainfarm in July increase by 19%

June Sales of Olainfarm Increase by 37%

on 15 liepos, 2015 Komentavimas išjungtas įraše June Sales of Olainfarm Increase by 37%

Preliminary consolidated sales results of JSC Olainfarm for June 2015 show that sales have reached 7.17 million euros, which represents an increase by 37% compared to the same period one year ago. The biggest sales increases were achieved in Georgia, where sales grew by 3346% and in Ukraine, where sales grew by 431%. Sales to Turkmenistan grew by 76%, but sales to Tajikistan grew by 71%. Significant shipments have also been made to UK and Germany. Biggest sales markets of JSC Olainfarm during June 2015 were Russia, Latvia, Ukraine, UK and Belarus.

June 2015, consolidated sales Share in total sales Changes to June 2014
Russia 25% 31%
Latvia 23% 11%
Ukraine 17% 431%
UK 9% NA
Belarus 6% -36%
Tajikistan 3% 71%
Germany 2% NA
Georgia 2% 3346%
Turkmenistan 2% 76%
Kazakhstan 1% -67%
Other 10% -26%
Total 100% 37%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. fully owned by JSC Olainfarm were 1.32 million euros, which represents an increase by 16% compared to the same period of 2014.  Fifty-eight pharmacies were operating during this period.  Sales of Silvanols Ltd. in June 2015 were 0.38 million euros, which represents an increase by 65%, compared to sales made in June 2014. During May Silvanols Ltd. was selling its products to nine European countries.

In six months of 2015, according to preliminary consolidated results, sales of JSC Olainfarm were 51.05 million euros, which represents an increase by 5% compared to the same period of 2014.  The most rapid sales increases in this period were achieved in The Netherlands, where sales grew by 209%, sales to Tajikistan grew by 46%. The biggest sales markets of JSC Olainfarm during the first six months of 2015 were Russia, Latvia, Ukraine, The Netherlands and Belarus.

6 months of 2015, consolidated sales Share in total sales Changes to 6 months of 2014
Russia 34% 5%
Latvia 22% 10%
Ukraine 12% -20%
The Netherlands 8% 209%
Belarus 7% -20%
UK 3% -10%
Kazakhstan 2% 15%
Tajikistan 1% 46%
Uzbekistan 1% -49%
Lithuania 1% 7%
Other 9% 12%
Total 100% 5%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in six months were 8.24 million euros, which represents an 11% increase compared to six months of 2014. Sales of Silvanols Ltd. in six months of 2015 were 2 million euros, which means an increase by 31% compared to six months of 2014, when Silvanols Ltd. made sales of 1.523 million euros. In six months of 2015, Silvanols Ltd. made sales to 11 countries on two continents.

According to unconsolidated sales results of JSC Olainfarm, sales of the company in June 2015 were 6.17 million euro, which represents an increase by 42% compared to the same period one year ago. The biggest sales increases were achieved in Georgia, where sales grew by 2539% and in Ukraine, where sales grew by 431%. Sales to Turkmenistan grew by 76%, but sales to Tajikistan grew by 71%. Significant shipments were also made to UK and Germany. The major sales markets of JSC Olainfarm in June 2015 were Russia, Ukraine, Latvia, UK and Belarus. In total during June 2015, JSC Olainfarm sold its products in 21 countries on three continents.

June 2015, unconsolidated sales Share in total sales Changes to June 2014
Russia 29% 31%
Ukraine 20% 431%
Latvia 15% 32%
UK 11% NA
Belarus 7% -36%
Tajikistan 4% 71%
Germany 2% NA
Turkmenistan 2% 76%
Kazakhstan 2% -67%
Georgia 2% 2539%
Other 8% -42%
Total 100% 42%

 

In six months of 2015, according to preliminary unconsolidated results, the sales of JSC Olainfarm were 45.02 million euros, which represents an increase by 6% compared to the respective period of 2014. The most rapid sale increases were achieved in The Netherlands, Kyrgyzstan, Tajikistan and Latvia, where sales respectively grew by 209%, 60%, 46% and 36%. According to preliminary unconsolidated sales results, the major sales markets of JSC Olainfarm in six months of 2015 were Russia, Ukraine, Latvia, the Netherlands and Belarus. In total in six months of 2015, JSC Olainfarm sold its products in 37 countries on five continents.

6 months of 2015, unconsolidated sales Share in total sales Changes to 6 months of 2014
Russia 38% 5%
Ukraine 14% -20%
Latvia 14% 36%
The Netherlands 9% 209%
Belarus 8% -20%
UK 3% -10%
Kazakhstan 3% 15%
Tajikistan 1% 46%
Uzbekistan 1% -49%
Kirgizstan 1% 60%
Other 8% -2%
Total 100% 6%

 

Annual General Meeting of shareholders of JSC Olainfarm, held on June 11, 2015 approved operating plan of the company, according to which the unconsolidated sales of the Company in 2015 will reach 87 million euros, while consolidated sales will reach 100 million euro.  According to these preliminary sales figures, in six months of 2015, the Company has attained 52% of annual target for unconsolidated sales and 51% of annual target for consolidated sales.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

read more
June Sales of Olainfarm Increase by 37%

Sales of Olainfarm in May Reach 7.11 Million Euro

on 15 birželio, 2015 Komentavimas išjungtas įraše Sales of Olainfarm in May Reach 7.11 Million Euro

Preliminary consolidated sales results of JSC Olainfarm for May 2015 show that sales have reached 7.11 million euro, which represents a reduction by a third comparing to the same period one year ago.  The biggest sales increases were achieved in Moldova, where sales grew by 651% and in The Netherlands, where sales grew by 500%.  During May 2015, JSC Olainfarm also made significant shipments to Switzerland. Biggest sales markets of JSC Olainfarm during May 2015 were Russia, The Netherlands, Latvia, Ukraine and Belarus.

May 2015, consolidated sales Share in total sales Changes to May 2014
Russia 27% -31%
The Netherlands 15% 500%
Latvia 24% 11%
Ukraine 9% -79%
Belarus 7% -12%
Kazakhstan 3% 33%
Poland 3% -26%
Uzbekistan 2% -69%
Switzerland 2% NA
Moldova 1% 651%
Other 7% -69%
Total 100% -33%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. fully owned by JSC Olainfarm were 1.3 million euros, which represents an increase by 9% compared to the same period of 2014.  Fifty-eight pharmacies were operating during this period.  Sales of Silvanols Ltd. in May 2015 were 0.2 million euro, which represents an increase by 43%, compared to sales made in May 2014.   During May Silvanols Ltd. was selling its products to five European countries.

In five months of 2015, according to preliminary consolidated results, sales of JSC Olainfarm were 43.82 million euros, which represents an increase by 1% compared to the same period of 2014.  The most rapid sales increases during this period were achieved in The Netherlands, where sales grew by 251%, sales to Kyrgyzstan grew by 88%, sales to Kazakhstan grew by 53%, but sales to Tajikistan grew by 36%.  The biggest sales markets of JSC Olainfarm in five months of 2015 were Russia, Latvia, Ukraine, The Netherlands and Belarus.

5 months of 2015, consolidated sales Share in total sales Changes to 5 months of 2014
Russia 36% 2%
Latvia 22% 9%
Ukraine 11% -33%
The Netherlands 9% 251%
Belarus 7% -17%
Kazakhstan 2% 53%
UK 2% -50%
Uzbekistan 1% -49%
Kyrgyzstan 1% 88%
Tajikistan 1% 36%
Other 8% 8%
Total 100% 1%

 

Sales of pharmacy chain of Latvijas Aptieka Ltd. in five months were 6.9 million euros, which represents a 10% increase compared to 5 months of 2014.  Sales of Silvanols Ltd. in five months of 2105 were 1.6 million euros, which means an increase by 23% compared to five months of 2014, when Silvanols Ltd. made sales of 1.3 million euro. In five months of 2015, Silvanols Ltd. made sales to 11 countries on two continents.

According to unconsolidated sales results of JSC Olainfarm, sales of the company in May 2015 were 6.24 million euro, which represents a reduction by 36% compared to the same period one year ago.  The biggest sales increases were achieved in Moldova, where sales grew by 651% and in The Netherlands, where sales grew by 500%.  Significant shipments were also made to Switzerland.  The major sales markets of JSC Olainfarm in May 2015 were Russia, The Netherlands, Latvia, Ukraine and Belarus.  In total during May 2015, JSC Olainfarm sold its products in 25 countries on four continents.

May 2015, unconsolidated sales Share in total sales Changes to May, 2014
Russia 31% -31%
The Netherlands 17% 500%
Latvia 15% 28%
Ukraine 11% -79%
Belarus 8% -12%
Kazakhstan 3% 33%
Poland 3% -35%
Uzbekistan 2% -69%
Switzerland 2% NA
Moldova 1% 651%
Other 7% -72%
Total 100% -36%

 

In five months of 2015, according to preliminary unconsolidated results the sales of JSC Olainfarm were 38.8 million euro, which represents an increase by 2% compared to the respective period of 2014. The most rapid sale increases were achieved in The Netherlands, Kyrgyzstan, Kazakhstan, Tajikistan and Latvia, where sales respectively grew by 251%, 88%, 53%, 36% and 35%.  According to preliminary unconsolidated sales results, the major sales markets of JSC Olainfarm in five months of 2015 were Russia, Latvia, Ukraine, The Netherlands and Belarus. In total in five months of 2015, JSC Olainfarm sold its products in 36 countries on five continents.

5 months of 2015, unconsolidated sales Share in total sales Changes to 5 months of 2014
Russia 40% 2%
Latvia 13% 35%
Ukraine 13% -33%
The Netherlands 10% 251%
Belarus 8% -17%
Kazakhstan 3% 53%
UK 2% -50%
Uzbekistan 1% -49%
Kyrgyzstan 1% 88%
Tajikistan 1% 36%
Other 7% -4%
Total 100% 2%

 

Annual General Meeting of shareholders of JSC Olainfarm, held on June 11, 2015 approved operating plan of the company, according to which the unconsolidated sales of the Company in 2015 will reach 87 million euros, while consolidated sales will reach 100 million euro.  According to these preliminary sales figures, in five months of 2015, the Company has attained 45% of annual target for unconsolidated sales and 44% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

 

read more
Sales of Olainfarm in May Reach 7.11 Million Euro

Decisions Adopted by the Annual General Meeting of Shareholders

on 11 birželio, 2015 Komentavimas išjungtas įraše Decisions Adopted by the Annual General Meeting of Shareholders

The following decisions have been adopted by the annual general meeting of shareholders:

1. Report of the Board on results of operations in 2014.

To take notice of the Report of the Board on results of operations in year 2014.

Voting: the resolution was adopted with the necessary majority of votes.

2. Report of the Council on results of operations in 2014.

To take notice of the Report of the Council on results of operations in year 2014.

Voting: the resolution was adopted with the necessary majority of votes.

3. Report of the Auditing Committee.

To take notice of the Report of the Auditing Committee.

Voting: the resolution was adopted with the necessary majority of votes.

4. Approval of JSC Olainfarm Consolidated and Parent company’s Annual report for year 2014.

To approve JSC Olainfarm Consolidated and Parent mother company’s Annual report for year 2014.

Voting: the resolution was adopted with the necessary majority of votes.

5. Distribution of profit of 2014.

To reinvest the profit of JSC Olainfarm for year 2014 in amount of  EUR 11 424 000.00 (eleven million four hundred twenty four thousand euro, 00 cents) in the development of JSC Olainfarm.

Voting: the resolution was adopted with the necessary majority of votes.

6.Report of the Management Board about the budget and operational plan for 2015.

To take notice of Report of the Board on budget and operational plan for 2015, which include Company’s unconsolidated turnover forecast for 2015 in amount of 87 million Euro; Forecast of unconsolidated profit of JSC Olainfarm in amount of 14 million Euro, but consolidated turnover forecast for amount of 100 million Euro and profit consolidated profit forecast for amount of 15 million Euro.

Voting: the resolution was adopted with the necessary majority of votes.

7. Elections of the sworn auditor for 2015 and setting of the remuneration for the sworn auditor.

7.1. To elect SIA Ernst & Young Baltic (license No.17, unitary registration No. 40003593454) to be the certified auditor of JSC Olainfarm in 2015.

Voting: the resolution was adopted with the necessary majority of votes.

7.2.  Set the total remuneration of certified auditor for 2015 in amount of 42 450.00 Euro.

Voting: the resolution was adopted with the necessary majority of votes.

8. Elections of the Auditing Committee for 2015 and setting of the remuneration of the Auditing Committee.

8.1.To elect Mr. Viesturs Gurtlavs  to be the member of the Auditing Committee.

Voting: the resolution was adopted with the necessary majority of votes.

8.2. Set the total monthly remuneration of the member of the Auditing Committee at EUR 4 200.00.

Voting: the resolution was adopted unanimously.

9. Approval of Regulations for Auditing Committee.

To approve the Regulations for Auditing Committee.

Voting: the resolution was adopted with the necessary majority of votes.

 

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

 

read more
Decisions Adopted by the Annual General Meeting of Shareholders

First Quarter 2015 Investor Conference Webinar

on 10 birželio, 2015 Komentavimas išjungtas įraše First Quarter 2015 Investor Conference Webinar

On June 9 JSC Olainfarm organized its first quarter 2015 Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of first quarter 2015 and informed about the company’s future activities, this time paying extra attention to company’s Tajikistan, Kyrgyzstan and Turkmenistan markets.

The recorded Olainfarm webinar is available online: ej.uz/Olainfarm_Q1_2015, and the presentation, demonstrated during the webinar, can be found in the previously published company’s announcement: https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=664216&messageId=826964.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

 

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

read more
First Quarter 2015 Investor Conference Webinar

Olainfarm Holds First Quarter 2015 Investor Conference Webinar

on 9 birželio, 2015 Komentavimas išjungtas įraše Olainfarm Holds First Quarter 2015 Investor Conference Webinar

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its first quarter 2015 investor conference webinar scheduled on June 9, 2015 at 16:00 (EET). Please note that attendees have to register for the webinar – detailed information on the registration process is available below.

During the webinar Salvis Lapins will inform about JSC Olainfarm latest activities and analyze the non-audited financial results of the first quarter 2015 and audited financial results of 2014. After the presentation investors are welcome to ask questions. During the webinar the enclosed presentation will be presented: Webinar Presentation: 1st quarter of 2015

How to join the webinar?
All you need is a computer with internet connection and headphones.

To join the webinar, we invite you to register via http://ej.uz/OLF_1Q2015.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.

For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

read more
Olainfarm Holds First Quarter 2015 Investor Conference Webinar

Search

Recent Posts